Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Karp HQ"'
Autor:
Vedula RS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Karp HQ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Koob J; Broad Institute of MIT and Harvard, Cambridge, MA., Lim F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Winer ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ghiaur G; Johns Hopkins Medical Institute, Baltimore, MD., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Beppu LW; Fred Hutchinson Cancer Center, Seattle, WA., Sala-Torra O; Fred Hutchinson Cancer Center, Seattle, WA., Radich J; Fred Hutchinson Cancer Center, Seattle, WA., Gootenberg J; McGovern Institute, Cambridge, MA., Abudayyeh O; McGovern Institute, Cambridge, MA., Zhang F; Broad Institute of MIT and Harvard, Cambridge, MA., Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood [Blood] 2024 Sep 19; Vol. 144 (12), pp. 1290-1299.
Autor:
Schaefer EJ; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Wang HC; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Karp HQ; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Meyer CA; Department of Data Science, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Gearhart MD; Developmental Biology Center, Masonic Cancer Center, and Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota., Adelman ER; Sylvester Comprehensive Cancer Center, Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida.; Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, Florida., Fares I; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Apffel A; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Lim K; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Gibson CJ; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Schenone M; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Murdock HM; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Wang ES; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Gondek LP; Division of Molecular Pathology, Department of Pathology, Johns Hopkins University, Baltimore, Maryland., Carroll MP; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Vedula RS; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Winer ES; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Garcia JS; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Stone RM; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Luskin MR; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts., Carr SA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Bardwell VJ; Developmental Biology Center, Masonic Cancer Center, and Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota., Figueroa ME; Sylvester Comprehensive Cancer Center, Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida., Lindsley RC; Department of Medical Oncology, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2022 Mar 01; Vol. 3 (2), pp. 116-135.
Autor:
Garcia JS; Department of Medical Oncology, and., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; and., Murdock HM; Department of Medicine., Cutler CS; Department of Medical Oncology, and., Brock J; Department of Medical Oncology, and., Gooptu M; Department of Medical Oncology, and., Ho VT; Department of Medical Oncology, and., Koreth J; Department of Medical Oncology, and., Nikiforow S; Department of Medical Oncology, and., Romee R; Department of Medical Oncology, and., Shapiro R; Department of Medical Oncology, and., Loschi F; Department of Medical Oncology, and., Ryan J; Department of Medical Oncology, and., Fell G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; and., Karp HQ; Department of Medical Oncology, and., Lucas F; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Potter D; Department of Medical Oncology, and., Mashaka T; Department of Medical Oncology, and., Stone RM; Department of Medical Oncology, and., DeAngelo DJ; Department of Medical Oncology, and., Letai A; Department of Medical Oncology, and., Lindsley RC; Department of Medical Oncology, and., Soiffer RJ; Department of Medical Oncology, and., Antin JH; Department of Medical Oncology, and.
Publikováno v:
Blood advances [Blood Adv] 2021 Dec 28; Vol. 5 (24), pp. 5536-5545.